Table 2.
Characteristic | Group 1 (n = 19) | Group 2 (n = 18) | p |
---|---|---|---|
Gender (male/female) | 15:4 | 14:4 | 0.93 |
Age (years) | 60 (35–70) | 60 (43–74) | 0.75 |
Urine protein (g/day) | 3.7 (1.0–7.5) | 3.3 (1.3–7.1) | 0.80 |
Serum levels | |||
Urea nitrogen (mg/dL) | 14.5 (7.0–23.7) | 15.1 (7.0–29.0) | 0.81 |
Creatinine (mg/dL) | 0.8 (0.5–1.3) | 0.9 (0.6–1.4) | 0.37 |
Uric acid (mg/dL) | 5.7 (3.7–8.5) | 6.4 (4.4–9.2) | 0.27 |
Total protein (g/dL) | 4.7 (3.9–5.5) | 4.7 (3.3–6.2) | 0.15 |
Albumin (g/dL) | 2.5 (1.8–3.4) | 2.6 (1.0–3.9) | 0.59 |
Total cholesterol (mg/dL) | 351 (188–769) | 300 (187–390) | 0.17 |
The data were at 4 weeks of PSL-alone treatment and just before PSL and MZR combined therapy
Age and laboratory data are shown as medians (interquartile range)
The p values were evaluated by Fisher’s exact test for gender and Mann–Whitney U test for the others